Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
3
×
crispr
3
×
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston top stories
cancer immunotherapy
clinical trials
gene therapy
gilead sciences
ipo
medicare
merck
What
bio
roundup
talk
acquisitions
announced
approval
becker
billions
biogen’s
biopharmaceutical
ceo
collabs
companies
convo
covid
daniel
deal
dollars
drug
earlier
eaton
failures
gene
gilead
gilead’s
healthcare
help
impact
introduce
ipo
life
littered
medicines
michael
millions
month
moves
nash
new
news
Language
unset
Current search:
crispr
×
cancer
×
biogen
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More